Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global metagenomics market size reached US$ 452.9 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 875 Million by 2027, exhibiting a growth rate (CAGR) of 11.41% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.
Metagenomics Market Trends:
The increasing prevalence of virus-induced infections, such as diarrhea, influenza, hepatitis B, and HIV/AIDS, across the globe, is among the key factors driving the market growth. Moreover, the rising demand for effective solutions for the timely diagnosis of neuroinfectious diseases, such as meningitis and encephalitis, is providing a thrust to the market growth. In line with this, metagenomics also aids in identifying bacterial pathogens that can lead to foodborne disease outbreaks, which is further contributing to the growth of the market. In comparison to the traditionally used technologies, metagenomics requires a lesser number of pre-sequencing steps, enhances the authenticity of long readings and offers high read accuracy. Additionally, various technological advancements, such as the development of next-generation sequencing services, are acting as other growth-inducing factors. These solutions are integrated with data analysis software for faster data analysis and sample processing. Other factors, including extensive research and development (R&D) activities in the field of life sciences, along with the increasing utilization of metagenomics for manufacturing sustainable agricultural products, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global metagenomics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology and application.
Breakup by Product:
Instruments and Software
Consumables
Breakup by Technology:
Sequencing
Bioinformatics
Breakup by Application:
Infectious Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Biotechnology
Biofuel
Agriculture
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global metagenomics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global metagenomics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global metagenomics market and who are the key players?
What is the degree of competition in the industry?
Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.
Metagenomics Market Trends:
The increasing prevalence of virus-induced infections, such as diarrhea, influenza, hepatitis B, and HIV/AIDS, across the globe, is among the key factors driving the market growth. Moreover, the rising demand for effective solutions for the timely diagnosis of neuroinfectious diseases, such as meningitis and encephalitis, is providing a thrust to the market growth. In line with this, metagenomics also aids in identifying bacterial pathogens that can lead to foodborne disease outbreaks, which is further contributing to the growth of the market. In comparison to the traditionally used technologies, metagenomics requires a lesser number of pre-sequencing steps, enhances the authenticity of long readings and offers high read accuracy. Additionally, various technological advancements, such as the development of next-generation sequencing services, are acting as other growth-inducing factors. These solutions are integrated with data analysis software for faster data analysis and sample processing. Other factors, including extensive research and development (R&D) activities in the field of life sciences, along with the increasing utilization of metagenomics for manufacturing sustainable agricultural products, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global metagenomics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology and application.
Breakup by Product:
Instruments and Software
Consumables
Breakup by Technology:
Sequencing
Bioinformatics
Breakup by Application:
Infectious Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Biotechnology
Biofuel
Agriculture
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global metagenomics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global metagenomics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global metagenomics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL METAGENOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Instruments and Software
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Sequencing
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Bioinformatics
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Infectious Disease Diagnosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Environmental Remediation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Gut Microbe Characterization
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Biotechnology
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Biofuel
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Agriculture
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Enterome
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Eurofins Scientific
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 F. Hoffmann-La Roche AG (Roche Holding AG)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Illumina Inc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Novogene Co. Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Oxford Nanopore Technologies Limited
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Pacific Biosciences of California Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 PerkinElmer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 QIAGEN N.V.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Swift Biosciences Inc. (Danaher Corporation)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL METAGENOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Instruments and Software
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Sequencing
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Bioinformatics
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Infectious Disease Diagnosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Environmental Remediation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Gut Microbe Characterization
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Biotechnology
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Biofuel
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Agriculture
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Enterome
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Eurofins Scientific
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 F. Hoffmann-La Roche AG (Roche Holding AG)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Illumina Inc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Novogene Co. Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Oxford Nanopore Technologies Limited
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Pacific Biosciences of California Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 PerkinElmer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 QIAGEN N.V.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Swift Biosciences Inc. (Danaher Corporation)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Metagenomics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Metagenomics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Metagenomics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Metagenomics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Metagenomics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Metagenomics Market: Competitive Structure
Table 7: Global: Metagenomics Market: Key Players
Table 1: Global: Metagenomics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Metagenomics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Metagenomics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Metagenomics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Metagenomics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Metagenomics Market: Competitive Structure
Table 7: Global: Metagenomics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Metagenomics Market: Major Drivers and Challenges
Figure 2: Global: Metagenomics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Metagenomics Market: Breakup by Product (in %), 2021
Figure 5: Global: Metagenomics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Metagenomics Market: Breakup by Application (in %), 2021
Figure 7: Global: Metagenomics Market: Breakup by Region (in %), 2021
Figure 8: Global: Metagenomics (Instruments and Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Metagenomics (Instruments and Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Metagenomics (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Metagenomics (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Metagenomics (Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Metagenomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Metagenomics (Bioinformatics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Metagenomics (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Metagenomics (Infectious Disease Diagnosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Metagenomics (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Metagenomics (Environmental Remediation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Metagenomics (Environmental Remediation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Metagenomics (Gut Microbe Characterization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Metagenomics (Gut Microbe Characterization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Metagenomics (Biotechnology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Metagenomics (Biotechnology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Metagenomics (Biofuel) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Metagenomics (Biofuel) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Metagenomics (Agriculture) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Metagenomics (Agriculture) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Metagenomics Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Metagenomics Industry: SWOT Analysis
Figure 78: Global: Metagenomics Industry: Value Chain Analysis
Figure 79: Global: Metagenomics Industry: Porter's Five Forces Analysis
Figure 1: Global: Metagenomics Market: Major Drivers and Challenges
Figure 2: Global: Metagenomics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Metagenomics Market: Breakup by Product (in %), 2021
Figure 5: Global: Metagenomics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Metagenomics Market: Breakup by Application (in %), 2021
Figure 7: Global: Metagenomics Market: Breakup by Region (in %), 2021
Figure 8: Global: Metagenomics (Instruments and Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Metagenomics (Instruments and Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Metagenomics (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Metagenomics (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Metagenomics (Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Metagenomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Metagenomics (Bioinformatics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Metagenomics (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Metagenomics (Infectious Disease Diagnosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Metagenomics (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Metagenomics (Environmental Remediation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Metagenomics (Environmental Remediation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Metagenomics (Gut Microbe Characterization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Metagenomics (Gut Microbe Characterization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Metagenomics (Biotechnology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Metagenomics (Biotechnology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Metagenomics (Biofuel) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Metagenomics (Biofuel) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Metagenomics (Agriculture) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Metagenomics (Agriculture) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Metagenomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Metagenomics Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Metagenomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Metagenomics Industry: SWOT Analysis
Figure 78: Global: Metagenomics Industry: Value Chain Analysis
Figure 79: Global: Metagenomics Industry: Porter's Five Forces Analysis
